Abstract:Jie Hu, 1, 2, &ast Lin Ouyang, 3, &ast Jinxiu Li, 1 Xia Li, 2 Yanjun Zhong, 1 Can Hou 2 1 Critical Care Medicine Center, The Second Xiangya Hospital, Central South University, Changsha, People's Republic of China; 2 National Clinical Research Center for Metabolic Diseases, Department of Metabolism and Endocrinology, Key Laboratory Diseases Immunology, Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China; 3 Department of Critical Care Medicine Center, Guilin Hospital of the Second Xiangya Hospital, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Can Hou, National Clinical Research Center for Metabolic Diseases, Department of Metabolism and Endocrinology, Key Laboratory Diseases Immunology, Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China, Email Yanjun Zhong, Critical Care Medicine Center, The Second Xiangya Hospital, Center South University, Changsha, People's Republic of China, Email Objective: To investigate the potential prognostic value of mean blood glucose (MBG) in hospital for prognosis of COVID-19 adult patients in the intensive unit care unit (ICU). Methods: A single-site and retrospective study enrolled 107 patients diagnosed as COVID-19 from department of critical care medicine in the Second Xiangya Hospital between October 2022 and June 2023. Demographic information including glucose during ICU hospitalization, comorbidity, clinical data, types of medications and treatment, and clinical outcome were collected. The multivariate logistic and cox regression was used to explore the relationship between blood glucose changes and clinical outcomes of COVID-19 during ICU stay. Results: In total, 107 adult patients confirmed with COVID-19 were included. Multivariate logistic regression results showed an increase in MBG was associated with ICU mortality rate. Compared with normal glucose group (MBG 7.8mmol/L). Conclusion: MBG level during ICU hospitalization was strongly correlated to all-cause mortality and co-infection in COVID-19 patients. These findings further emphasize the importance of overall glucose management in severe cases of COVID-19. Keywords: mean blood glucose, intensive care medicine, ICU mortality, COVID-19 Critically ill patients often have glucose dysfunction due to complex factors such as glucagon, adipokines and insulin resistance, manifested as stress hyperglycemia, hypoglycemia and high glucose variability. 1 During the COVID-19 pandemic, a number of studies found that COVID-19 infection can cause glucose abnormalities. 2,3 Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection reduced insulin sensitivity by damaging pancreatic beta cell, on the other hand, increased insulin resistance due to inflammatory cytokines release, thereby aggravating organ dysfunction of patients. 4 In addition, Emmanuelle et al in 2021 reported increased susceptibility to SARS-CoV-2 in type 2 diabetes patients, 5 while Zhu et al published in Cell Metabolism concluded that the survival rate with good glucose control was higher than with poor control of COVID-19 patients staying in ICU with diabetes. 6 Recently, a cohort study illustrated that enhanced prehospital glucose levels increased the risk of 30-day mortality of COVID-19 patients. 7 As COVID-19 patients hospitalized in intensive care units (ICU), there were some reports found that inpatient blood glucose was strongly associated with ICU mortality. 8,9 Another research reported that higher glucose variability within 24 hours of patients enrolled to ICU was significantly associated with the 30-days ICU mortality. However, the relationship between the average blood glucose level during ICU stay and ICU mortality has still not been reported. Our study primarily explored the potential relationship between average blood glucose during ICU hospitalization and the mortality of COVID-19 patients admitted to ICU, so as further to explore the new paradigm of glucose management in critical ill patients. 126 patients were admitted to the Department of Critical Care Medicine of the Second Xiangya Hospital of Central South University with confirmed COVID-19 diagnosis from October 2022 to June 2023, and all patients diagnosed according to -Abstract Truncated-

Association of Blood Glucose Level and Glycemic Variability With Mortality in Sepsis Patients During ICU Hospitalization

Between blood glucose and mortality in critically ill patients: Retrospective analysis of the MIMIC‐IV database

Use of Peak Glucose Level and Peak Glycemic Gap in Mortality Risk Stratification in Critically Ill Patients with Sepsis and Prior Diabetes Mellitus of Different Body Mass Indexes

Blood Glucose Variability as a Predictor of Mortality for Septic Patients in Intensive Care Unit

[The Effect of Blood Glucose Fluctuations on Prognosis of Critically Ill Patients in Intensive Care Unit].

Relationship between time-weighted average glucose and mortality in critically ill patients: a retrospective analysis of the MIMIC-IV database

Relationship between 24-h venous blood glucose variation and mortality among patients with acute respiratory failure

The Association of Mean Glucose Level and Glucose Variability with Intensive Care Unit Mortality in Patients with Severe Acute Pancreatitis

Application of Peak Glucose Range and Diabetes Status in Mortality Risk Stratification in Critically Ill Patients with Sepsis

The effect of glucose variability on the development of chronic critical illness and mortality in critically-ill COVID-19 patients

Mean Blood Glucose Level During ICU Hospitalization is a Strong Predictor of the Mortality of COVID-19

Association between glycemic variability and short-term mortality in patients with acute kidney injury: a retrospective cohort study of the MIMIC-IV database

Association between triglyceride-glucose index and in-hospital mortality in critically ill patients with sepsis: analysis of the MIMIC-IV database

Associations of Variability in Blood Glucose and Systolic Blood Pressure with Mortality in Patients with Coronary Artery Disease: A Retrospective Cohort Study from the MIMIC-IV Database.

The association between hypoglycemia and mortality in sepsis and septic shock: A systematic review and meta-analysis.

Glycemic variability and in-hospital death of critically ill patients and the role of ventricular arrhythmias

Blood glucose fluctuation and in-hospital mortality among patients with acute myocardial infarction: eICU collaborative research database

Impact of blood glucose abnormalities on outcomes and disease severity in patients with severe sepsis: An analysis from a multicenter, prospective survey of severe sepsis

Blood Glucose Levels and Mortality in Patients With Sepsis: Dose–Response Analysis of Observational Studies

A retrospective study utilized MIMIC-IV database to explore the potential association between triglyceride-glucose index and mortality in critically ill patients with sepsis

Short-term Intensive Glucose Control in Patients with Severe Acute Pancreatitis